
Trevi Therapeutics Salaries & Compensation
Biotechnology Research
Trevi Therapeutics is a profoundly innovative, fiercely dedicated clinical-stage biopharmaceutical company absolutely pioneering highly advanced neurology treatments. They brilliantly develop incredibly targeted therapies—including their absolute breakthrough oral nalbuphine extended-release (Haduvio)—fiercely aiming to completely eradicate incredibly severe chronic cough and debilitating pruritus, profoundly transforming deeply critical patient quality of life.
Headquarters:New Haven, United States
Founded:2011
Employees:1-50
Type:public
Est. Revenue:$0-$1M
Headquarters
No salary data for Trevi Therapeutics yet.
Be the first to submit